{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:46:25Z","timestamp":1785840385814,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jvs.2018.02.047","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T07:54:56Z","timestamp":1526975696000},"page":"1922-1932.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Ashlei C.","family":"Beiswenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem","family":"Harth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman H.","family":"Kumins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi H.","family":"Shishehbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.02.047_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1148\/radiology.204.1.9205227","article-title":"Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease","volume":"204","author":"Bosch","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2018.02.047_bib3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.02.047_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists\u2019 Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2018.02.047_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/ccd.21995","article-title":"Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?","volume":"74","author":"Mohler","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.02.047_bib6","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood.V92.5.1518","article-title":"A\u00a0double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans","volume":"92","author":"Bossavy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jvs.2018.02.047_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0735-1097(00)00817-2","article-title":"Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy","volume":"36","author":"Moshfegh","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.avsg.2012.05.001","article-title":"Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures","volume":"27","author":"Allemang","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/ejvs.2002.1794","article-title":"Increased platelet aggregation and activation in peripheral arterial disease","volume":"25","author":"Robless","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MCA.0000000000000469","article-title":"Comparison of plaque morphology between peripheral and coronary artery disease (from the CLARITY and ADAPT-DES IVUS substudies)","volume":"28","author":"Yin","year":"2017","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jvs.2018.02.047_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cardiores.2007.05.003","article-title":"Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease","volume":"75","author":"White","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvs.2018.02.047_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomized blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.02.047_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib17","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib19","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9149(96)00773-4","article-title":"Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial)","volume":"79","author":"Bovill","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011"},{"key":"10.1016\/j.jvs.2018.02.047_bib24","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 [updated June 2017]","article-title":"Assessing risk of bias in included studies. Chapter 8.","author":"Higgins","year":"2017"},{"key":"10.1016\/j.jvs.2018.02.047_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","article-title":"Assessing reporting biases. Chapter 10.","author":"Sterne","year":"2011"},{"key":"10.1016\/j.jvs.2018.02.047_bib26","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","article-title":"Including non-randomized studies. Chapter 13","author":"Reeves","year":"2011"},{"key":"10.1016\/j.jvs.2018.02.047_bib27","unstructured":"Deeks JJ, Higgins JP, Altman DG, on behalf of the Cochrane Statistical Methods Group. Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 [updated June 2017]. Available at: www.training.cochrane.org\/handbook. Accessed July 17, 2017."},{"key":"10.1016\/j.jvs.2018.02.047_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2018.02.047_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.116.025880","article-title":"Ticagrelor compared with clopidogrel in patients with prior lower extremity revascularization for peripheral artery disease","volume":"135","author":"Jones","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib30","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy\u2014the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1583\/13-4275MR.1","article-title":"Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease","volume":"20","author":"Strobl","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2018.02.047_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jcin.2017.02.013","article-title":"Extended duration dual antiplatelet therapy after coronary stenting among patients with peripheral arterial disease: a subanalysis of the Dual Antiplatelet Therapy study","volume":"10","author":"Secemsky","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.02.047_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients\u00a0with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamacardio.2016.2811","article-title":"Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: a subgroup analysis of the PRODIGY randomized clinical trial","volume":"1","author":"Franzone","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2018.02.047_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvs.2015.01.051","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease","volume":"62","author":"Armstrong","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jvs.2016.05.098","article-title":"Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization","volume":"64","author":"Soden","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvs.2011.03.003","article-title":"Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery","volume":"54","author":"Stone","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.avsg.2015.03.040","article-title":"Comparison of dual-antiplatelet therapy durations after endovascular revascularization of infrainguinal arteries","volume":"29","author":"Sarode","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib41","first-page":"e686","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jvs.2018.02.047_bib42","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2018.02.047_bib43","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.02.047_bib44","first-page":"1243","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2016.01.018","article-title":"Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial","volume":"175","author":"Berger","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib46","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2004.03.028","article-title":"Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","volume":"148","author":"Bhatt","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib48","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.02.047_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ahj.2013.12.020","article-title":"Design and rationale for the prevention of cardiovascular events in patients with prior heart attack using ticagrelor compared to placebo on a background of aspirin\u2014Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial","volume":"167","author":"Bonaca","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib50","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.02.047_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ahj.2010.07.034","volume":"160","author":"Valgimigli","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib52","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2010.07.038","volume":"160","author":"Mauri","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2018.02.047_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/CRD.0b013e3182455744","article-title":"Clopidogrel and genetic testing: is it necessary for everyone?","volume":"20","author":"Goswami","year":"2012","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jvs.2018.02.047_bib54","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.299.5.532","article-title":"Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome","volume":"299","author":"Ho","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.02.047_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacc.2013.10.018","article-title":"A\u00a0randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease","volume":"63","author":"Ford","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418308255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418308255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T01:18:56Z","timestamp":1590974336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521418308255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0741521418308255"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.02.047","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}